한글목차

세계의 전기 의약품 시장 전망은 병원, 연구 기관, 개인 사용자 시장에 기회가있을 것입니다. 세계의 전기 의약품 시장의 2025-2031년 연평균 성장률(CAGR)은 7.3%를 나타낼 전망입니다. 이 시장의 주요 성장 촉진요인은 고령 인구 증가와 이에 따른 신경계 및 심혈관 질환 유병률 증가, 그리고 기술적 발전입니다.

• Lucintel의 예측에서는 유형별로 비침습적 전기 치료 기기가 예측기간 동안 높은 성장을 이룰 전망입니다.
• 용도별로는 병원이 높은 성장을 이룰 것으로 예측되고 있습니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장이 예상됩니다.

전기 의약품 시장의 새로운 동향

세계의 전기 의약품 시장은 혁신적인 기술이 의료 서비스 제공 방식을 재편하면서 변혁적 변화를 겪고 있습니다. 특히 통증 관리 및 신경 조절에 사용되는 전기 치료 기기는 비침습적 특성과 효과성으로 인해 주목받고 있습니다. 다음 동향은 시장 성장과 전망에 상당한 역할을 하며, 전기 의약품이 최근 의학을 어떻게 혁신하고 있는지 보여줍니다.

• 웨어러블 전기 치료 기기 : 만성 질환 관리를 위한 웨어러블 전기 치료 기기의 인기가 높아지고 있습니다. 이러한 기기는 환자가 집에서 지속적인 치료를 받을 수 있게 하여 치료 순응도와 결과를 개선합니다. 원격의료의 부상과 함께 웨어러블 기기는 원격 모니터링을 가능하게 하여 통증, 수면 장애 및 기타 질환 치료에서의 접근성과 효과성을 높이고 있습니다.
• 신경 조절에 주력 : 심부 뇌 자극(DBS) 및 경두개 자기 자극(TMS)을 포함한 신경 조절 치료법은 파킨슨병, 우울증, 간질과 같은 신경학적 장애 치료에서 두각을 나타내고 있습니다. 이러한 치료법은 전기적 자극을 통해 뇌 활동을 개질하며 약물 치료에 대한 중요한 대안으로 자리잡았습니다. 맞춤형으로 세밀하게 조정 가능한 특성 덕분에 더욱 개인화된 치료 옵션이 제공됩니다.
• 디지털 헬스 기술과의 통합 : 전기치료 기기와 인공지능(AI), 사물인터넷(IoT), 클라우드 컴퓨팅 같은 디지털 헬스 기술의 융합은 치료 역량을 발전시키고 있습니다. AI는 환자 데이터 분석, 치료 결과 예측, 치료 프로토콜 최적화에 활용되고 있습니다. 이러한 통합은 실시간 데이터 제공과 치료 정확도 향상을 통해 환자 관리를 향상시킵니다.
• 규제 발전 : 전 세계 규제 기관들은 승인 절차를 간소화하고 명확한 지침을 마련함으로써 전기치료법의 급속한 진화에 적응하고 있습니다. 이는 혁신을 가속화하고 더 많은 전기치료 기기가 시장에 진입할 수 있도록 합니다. 특히 미국 FDA의 신경조절 기기 및 웨어러블 전기치료 기기 승인은 산업 성장을 촉진하고 있습니다.
• 맞춤형 전기치료제 치료법 : 개인 맞춤형 치료에 대한 수요가 개발의 진전을 촉진함에 따라 개인의 특정 요구에 맞춘 전기치료제 개발이 활발해지고 있습니다. 유전자 연구와 환자 데이터 분석 기술의 발전으로 전기치료제를 정밀하게 조정하여 다양한 만성 질환을 해결하고 치료 효과를 향상시키는 더 효과적인 솔루션을 제공할 수 있게 되었습니다.

이러한 신흥 동향은 치료 효과 향상, 환자 접근성 개선, 혁신 촉진을 통해 전 세계의 전기 의약품 시장을 혁신하고 있습니다. 웨어러블 기기, 디지털 통합, 신경조절 기술이 지속적으로 발전함에 따라, 전 세계의 전기 의약품 미래는 의료 제공자가 다양한 질환을 다루는 방식을 재편할 전망입니다.

전기 의약품 시장의 최근 동향

전 세계 전기 의약품 시장은 최근 의료 산업과 환자 결과 모두에 영향을 미치는 상당한 발전을 이루었습니다. 기술 혁신, 규제 변화, 비침습적 치료에 대한 수요 증가는 이 분야의 발전을 위한 길을 열었습니다. 다음 발전 사항은 시장을 촉진하는 주요 진전을 보여줍니다.

• 비침습적 통증 관리의 발전 : 비침습적 통증 관리에 주력하는 새로운 전기의학 기술이 주목받고 있습니다. 척수 자극기 및 경두개 자기 자극(TMS)과 같은 장치는 만성 통증 치료에 점점 더 많이 사용되며, 환자에게 오피오이드 약물보다 안전한 대안을 제공합니다. 이러한 치료법은 전기적 자극의 표적화와 모니터링이 개선되면서 더욱 개인화되고 있습니다.
• 신경계 질환을 위한 뇌 자극 치료에 대한 관심 증가 : 파킨슨병 및 우울증과 같은 신경계 질환 치료를 위한 뇌 자극 치료법이 더욱 정교해졌습니다. 새로운 이식형 장치와 TMS와 같은 비침습적 방법이 신경 활동을 조절하여 환자 결과를 개선하는 데 활용되고 있습니다. 특정 뇌 영역을 표적화하는 혁신으로 이러한 치료의 효과성을 향상시키고 있습니다.
• 웨어러블 전기 치료 기기 개발 : 작고 착용할 수 있는 전기 치료 기기의 개발로 환자는 집에서 치료를 받을 수 있습니다. 이 기기는 통증, 수면장애, 심지어 정신 건강 문제와 같은 증상에 대해 이동 중에도 쉽게 치료할 수 있습니다. 휴대성과 사용 편의성은 환자의 치료에 대한 충고를 향상시키고 치료 효과를 높이는 데 기여합니다.
• 새로운 전기 치료 기기의 규제 승인 : 미국 FDA와 같은 규제 기관은 더 많은 전기 치료 기기를 승인하고 새로운 치료법 시장에 신속하게 진입할 수 있습니다. 이러한 승인에는 새로운 신경조절 기기 및 웨어러블 전기 치료 기기가 포함되어 혁신적인 치료가 더 빨리 환자에게 제공됩니다. 규제의 진보는 또한 제품 개발을 위한 명확한 경로를 제공함으로써 혁신을 촉진하고 있습니다.
• 전기 의약품에서 AI와 데이터 분석의 통합 : 인공지능(AI)과 데이터 분석을 전기치료 기기에 통합함으로써 환자 치료가 혁신되고 있습니다. AI는 대규모 데이터셋을 분석하고 치료 반응을 예측하여 의료진이 치료 계획을 최적화하는 데 활용됩니다. AI와 실시간 데이터 활용은 전기치료 요법의 정밀도와 효과성을 향상시킬 잠재력을 지닙니다.

이러한 핵심 발전은 전 세계 전기 의약품 시장을 더욱 개인화되고 접근성 높으며 효과적인 치료 방향으로 이끌고 있습니다. 기술적 발전이 지속됨에 따라 환자들은 점점 더 정교하고 맞춤화된 치료법을 기대할 수 있으며, 이는 다양한 분야의 의료 관행을 혁신할 것입니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계의 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 전기 의약품 시장 : 유형별

• 개요
• 유형별 : 매력 분석
• 이식형 전기 치료 기기 : 동향과 예측(2019-2031년)
• 비침습적 전기 치료 기기 : 동향과 예측(2019-2031년)

제5장 세계의 전기 의약품 시장 : 용도별

• 개요
• 용도별 : 매력 분석
• 병원 : 동향과 예측(2019-2031년)
• 연구기관 : 동향과 예측(2019-2031년)
• 개인 사용자 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역별 : 세계의 전기 의약품 시장

제7장 북미의 전기 의약품 시장

• 개요
• 북미의 전기 의약품 시장(유형별)
• 북미의 전기 의약품 시장(용도별)
• 미국의 전기 의약품 시장
• 멕시코의 전기 의약품 시장
• 캐나다의 전기 의약품 시장

제8장 유럽의 전기 의약품 시장

• 개요
• 유럽의 전기 의약품 시장(유형별)
• 유럽의 전기 의약품 시장(용도별)
• 독일의 전기 의약품 시장
• 프랑스의 전기 의약품 시장
• 스페인의 전기 의약품 시장
• 이탈리아의 전기 의약품 시장
• 영국의 전기 의약품 시장

제9장 아시아태평양의 전기 의약품 시장

• 개요
• 아시아태평양의 전기 의약품 시장(유형별)
• 아시아태평양의 전기 의약품 시장(용도별)
• 일본의 전기 의약품 시장
• 인도의 전기 의약품 시장
• 중국의 전기 의약품 시장
• 한국의 전기 의약품 시장
• 인도네시아의 전기 의약품 시장

제10장 기타 지역의 전기약 시장

• 개요
• 기타 지역의 전기 의약품 시장(유형별)
• 기타 지역의 전기 의약품 시장(용도별)
• 중동의 전기 의약품 시장
• 남미의 전기 의약품 시장
• 아프리카의 전기 의약품 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 전기 의약품 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴, 합작 사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 프로파일

• Competitive Analysis
• Medtronic
• St Jude Medical
• Boston Scientific Corporation
• Cochlear Limited
• Sonova Holding AG
• Livanova
• Biotronik

제14장 부록

• 도표 일람
• 표 목록
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• 당사에 대해
• 문의

영문목차

The future of the global electroceutical medicine market looks promising with opportunities in the hospitals, research institutes, and individual users markets. The global electroceutical medicine market is expected to grow with a CAGR of 7.3% from 2025 to 2031. The major drivers for this market are the rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders and the technological advancements.

• Lucintel forecasts that, within the type category, non-invasive electroceuticals devices is expected to witness higher growth over the forecast period.
• Within the application category, hospitals is expected to witness the higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Electroceutical Medicine Market

The global electroceutical medicine market is undergoing transformative changes, with innovative technologies reshaping healthcare delivery. Electrotherapy devices, particularly those used for pain management and neuromodulation, are gaining traction due to their non-invasive nature and effectiveness. The following trends are playing a significant role in the market's growth and future trajectory, indicating how electroceuticals are revolutionizing modern medicine.

• Wearable Electroceutical Devices: Wearable electroceutical devices are becoming increasingly popular for managing chronic conditions. These devices allow patients to receive continuous therapy at home, improving patient compliance and outcomes. With the rise of telemedicine, wearable devices are enabling remote monitoring, increasing their accessibility and effectiveness in treating pain, sleep disorders, and other conditions.
• Focus on Neuromodulation: Neuromodulation therapies, including deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), are gaining prominence in treating neurological disorders like Parkinson's disease, depression, and epilepsy. These therapies alter brain activity through electrical impulses and have become vital alternatives to pharmacological treatments. The ability to customize and fine-tune these therapies offers more personalized care options.
• Integration with Digital Health Technologies: The convergence of electroceutical devices with digital health technologies like AI, IoT, and cloud computing is advancing treatment capabilities. AI is being used to analyze patient data, predict outcomes, and optimize treatment protocols. This integration enhances patient care by providing real-time data and improving therapeutic accuracy.
• Regulatory Advancements: Regulatory bodies worldwide are adapting to the rapid evolution of electroceutical therapies by streamlining approval processes and creating clearer guidelines. This is accelerating innovation and allowing more electroceutical devices to enter the market. In particular, the U.S. FDA's approval of neuromodulation devices and wearable electroceuticals is fueling industry growth.
• Personalized Electroceutical Therapies: The demand for personalized treatments is driving the development of electroceutical therapies tailored to an individual's specific needs. With advancements in genetic research and patient data analytics, electroceuticals can be fine-tuned to offer more effective solutions for patients, addressing various chronic conditions and enhancing treatment outcomes.

These emerging trends are revolutionizing the electroceutical medicine market by enhancing treatment effectiveness, improving patient accessibility, and fostering innovation. As wearable devices, digital integration, and neuromodulation technologies continue to advance, the electroceutical landscape is set to reshape how healthcare providers address a wide range of medical conditions.

Recent Developments in the Electroceutical Medicine Market

The global electroceutical medicine market has seen significant developments recently, impacting both the healthcare industry and patient outcomes. Technological innovations, regulatory changes, and increasing demand for non-invasive therapies have paved the way for progress in this sector. The following developments highlight the key advancements driving the market forward.

• Advancement in Non-Invasive Pain Management: New electroceutical technologies focusing on non-invasive pain management are gaining prominence. Devices like spinal cord stimulators and transcranial magnetic stimulation (TMS) are increasingly used for chronic pain, offering patients a safer alternative to opioid medications. These therapies are also becoming more personalized through better targeting and monitoring of the electrical impulses.
• Increased Focus on Brain Stimulation for Neurological Disorders: Brain stimulation therapies, particularly for treating neurological conditions like Parkinson's disease and depression, have become more refined. New implantable devices and non-invasive methods like TMS are being used to regulate neural activity, improving patient outcomes. Innovations in targeting specific brain regions are enhancing the effectiveness of these treatments.
• Development of Wearable Electroceutical Devices: The development of compact, wearable electroceutical devices is making treatments more accessible to patients at home. These devices offer convenient, on-the-go therapies for conditions such as pain, sleep disorders, and even mental health issues. Their portability and ease of use contribute to improving patient adherence to therapy, thereby enhancing treatment efficacy.
• Regulatory Approvals for Novel Electroceutical Devices: Regulatory bodies like the U.S. FDA have been approving more electroceutical devices, enabling faster entry of novel therapies into the market. These approvals include new neuromodulation and wearable electrotherapy devices, making innovative treatments available to patients more quickly. Regulatory advancements are also fostering innovation by providing clearer pathways for product development.
• Integration of AI and Data Analytics in Electroceutical Therapy: The integration of artificial intelligence (AI) and data analytics with electroceutical devices is transforming patient care. AI is used to analyze large datasets and predict therapeutic responses, helping healthcare providers optimize treatment plans. The use of AI and real-time data has the potential to improve the precision and effectiveness of electroceutical therapies.

These key developments are pushing the global electroceutical medicine market toward more personalized, accessible, and effective treatments. As technological advancements continue to emerge, patients can expect increasingly sophisticated and tailored therapies, revolutionizing healthcare practices across various sectors.

Strategic Growth Opportunities in the Electroceutical Medicine Market

The electroceutical medicine market is experiencing rapid growth, driven by advancements in technology, healthcare needs, and patient demand for non-invasive treatments. Key applications in pain management, neuromodulation, and rehabilitation are seeing significant strategic growth opportunities, offering new avenues for innovation and expansion. The following opportunities are shaping the future of the market.

• Pain Management: Electroceuticals are increasingly being used for non-invasive pain management, particularly for chronic pain conditions such as back pain, arthritis, and migraines. The development of advanced wearable devices and spinal cord stimulators is offering patients effective alternatives to opioid medications, driving growth in this segment.
• Neuromodulation for Mental Health: Neuromodulation therapies, such as transcranial magnetic stimulation (TMS), are expanding for treating mental health conditions like depression and anxiety. These non-invasive treatments are becoming more widely accepted due to their efficacy in patients who do not respond to traditional pharmaceutical treatments, opening new markets in mental health therapy.
• Rehabilitation and Recovery: Electroceuticals are increasingly used in rehabilitation, especially for patients recovering from stroke, spinal cord injuries, or neurological disorders. Electrotherapy devices designed to stimulate muscles and nerves are helping to accelerate recovery times and improve motor function, which is driving growth in the rehabilitation sector.
• Wearable Devices for Home Use: The demand for wearable electroceutical devices is rising as patients seek more convenient, at-home treatment options. Wearable devices designed for chronic conditions like pain management, sleep disorders, and depression provide patients with consistent therapy and contribute to improved patient compliance, creating a significant market opportunity.
• Regenerative Electroceuticals: Electroceuticals designed to promote tissue regeneration and healing are gaining traction, particularly in orthopedics and wound healing. Devices that stimulate the body's natural healing processes are becoming more popular in medical practices, offering an exciting growth opportunity for regenerative therapies.

These strategic growth opportunities are driving the expansion of the electroceutical medicine market. As new technologies emerge and healthcare providers continue to embrace non-invasive treatments, the market for electroceuticals is poised for continued growth across key applications.

Electroceutical Medicine Market Driver and Challenges

The global electroceutical medicine market is being shaped by various technological, economic, and regulatory factors. While advancements in technology and increasing demand for non-invasive treatments are driving growth, challenges related to regulatory hurdles, costs, and patient adoption persist. The following drivers and challenges are central to the market's development.

The factors responsible for driving the electroceutical medicine market include:

1. Technological Advancements: The rapid progress in electrotherapy devices, including neuromodulation and wearable technologies, is one of the primary drivers. These innovations are making treatments more effective, non-invasive, and personalized, thereby increasing patient demand for electroceutical therapies.

2. Rising Demand for Non-Invasive Treatments: As healthcare professionals and patients seek alternatives to invasive surgeries and pharmaceutical drugs, the demand for non-invasive therapies like electroceuticals is growing. These therapies are considered safer, with fewer side effects, which is contributing to their increased adoption across various medical fields.

3. Government Support and Funding: Many governments worldwide are providing funding and regulatory support to promote the development and adoption of electroceutical therapies. Initiatives such as grants, tax incentives, and fast-tracking regulatory approvals are driving market expansion and encouraging innovation in the sector.

4. Aging Population: The global aging population is a significant driver of the electroceutical market, particularly in countries like Japan and Germany. As older adults face increasing health issues such as chronic pain and neurological disorders, the demand for electroceutical therapies to improve their quality of life is rising.

5. Growing Awareness and Acceptance of Electroceuticals: Increasing awareness among patients and healthcare professionals about the benefits of electroceuticals is driving market growth. As more patients seek alternatives to traditional treatments, electroceutical therapies are becoming more accepted, particularly in pain management and mental health.

Challenges in the electroceutical medicine market are:

1. High Development Costs: Developing electroceutical devices requires significant investment in research, development, and regulatory approvals. These high costs can be a barrier to entry for smaller companies and may limit the affordability of electroceutical devices for some patients.

2. Regulatory and Reimbursement Issues: Despite recent advancements, regulatory approval processes can still be slow and complicated, especially for novel therapies. Additionally, reimbursement policies for electroceutical devices are still developing, which may limit their adoption in some regions.

3. Patient Hesitancy: Despite the benefits, some patients are still hesitant to adopt electroceutical treatments due to lack of awareness or fear of new technologies. Overcoming this resistance is a challenge that the market will need to address as adoption grows.

The drivers of technological advancements, increased demand for non-invasive treatments, and government support are contributing to the growth of the electroceutical medicine market. However, challenges such as high development costs, regulatory hurdles, and patient hesitancy must be addressed to maximize the potential of this growing industry.

List of Electroceutical Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies electroceutical medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the electroceutical medicine companies profiled in this report include-

• Medtronic
• St Jude Medical
• Boston Scientific Corporation
• Cochlear Limited
• Sonova Holding AG
• Livanova
• Biotronik

Electroceutical Medicine Market by Segment

The study includes a forecast for the global electroceutical medicine market by type, application, and region.

Electroceutical Medicine Market by Type [Value from 2019 to 2031]:

• Implantable Electroceuticals Devices
• Non-invasive Electroceuticals Devices

Electroceutical Medicine Market by Application [Value from 2019 to 2031]:

• Hospitals
• Research Institutes
• Individual Users
• Others

Electroceutical Medicine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Electroceutical Medicine Market

The global electroceutical medicine market has witnessed significant advancements, particularly across the United States, China, Germany, India, and Japan. With increasing adoption of electrotherapy devices and the growing integration of cutting-edge technology into healthcare, this market is evolving rapidly. Key countries are investing in innovative therapies for pain management, neuromodulation, and other medical conditions, further transforming the future of electroceutical medicine.

• United States: The U.S. remains a leading player in the global electroceutical medicine market. Notable advancements include the growing use of neuromodulation technologies for chronic pain management, particularly transcranial magnetic stimulation (TMS) for depression and other neurological disorders. Additionally, the FDA has fast-tracked approvals for several electroceutical devices, stimulating further growth. The U.S. healthcare system continues to embrace these treatments as alternatives to traditional pharmaceuticals, driven by the demand for non-invasive therapies.
• China: China's electroceutical medicine market is expanding rapidly due to advancements in healthcare infrastructure and government support. The country has witnessed a rise in demand for electrotherapy devices, especially for rehabilitation and pain management. China's large patient base, coupled with government-backed initiatives to promote innovation in medical technology, is driving growth. Notably, Chinese researchers are making strides in developing affordable electroceutical therapies, which are expected to cater to both domestic and international markets.
• Germany: Germany stands at the forefront of electroceutical research and innovation in Europe. The country has been increasingly integrating electroceutical therapies into clinical practice, especially for neurological disorders and musculoskeletal conditions. German medical device manufacturers are also pioneering in wearable electroceutical devices, combining cutting-edge technology with traditional therapeutic approaches. Strong government regulations and support for medical innovation further enable Germany to play a critical role in global electroceutical advancements.
• India: India's electroceutical medicine market is experiencing rapid growth due to a rising demand for affordable healthcare solutions. Increasing awareness of non-invasive treatments for chronic pain, neurological disorders, and rehabilitation is contributing to market expansion. The Indian government is promoting the development of innovative medical technologies, which includes funding for electroceutical research. Furthermore, India's growing healthcare sector and demand for cost-effective solutions are driving adoption across hospitals and clinics.
• Japan: Japan's electroceutical market is driven by technological innovations and its aging population. The country has seen notable progress in electrotherapy devices for pain relief and improving mobility in the elderly. Japan's government is actively supporting the development and integration of electroceutical technologies in healthcare, with the Ministry of Health, Labour and Welfare (MHLW) providing funding for research. These advancements are making electroceutical treatments more accessible to the elderly, who are a key demographic in the nation.

Features of the Global Electroceutical Medicine Market

• Market Size Estimates: Electroceutical medicine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Electroceutical medicine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Electroceutical medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the electroceutical medicine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the electroceutical medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the electroceutical medicine market by type (implantable electroceuticals devices and non-invasive electroceuticals devices), application (hospitals, research institutes, individual users, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Electroceutical Medicine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Implantable Electroceuticals Devices: Trends and Forecast (2019-2031)
• 4.4 Non-invasive Electroceuticals Devices: Trends and Forecast (2019-2031)

5. Global Electroceutical Medicine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospitals: Trends and Forecast (2019-2031)
• 5.4 Research Institutes: Trends and Forecast (2019-2031)
• 5.5 Individual Users: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Electroceutical Medicine Market by Region

7. North American Electroceutical Medicine Market

• 7.1 Overview
• 7.2 North American Electroceutical Medicine Market by type
• 7.3 North American Electroceutical Medicine Market by application
• 7.4 United States Electroceutical Medicine Market
• 7.5 Mexican Electroceutical Medicine Market
• 7.6 Canadian Electroceutical Medicine Market

8. European Electroceutical Medicine Market

• 8.1 Overview
• 8.2 European Electroceutical Medicine Market by type
• 8.3 European Electroceutical Medicine Market by application
• 8.4 German Electroceutical Medicine Market
• 8.5 French Electroceutical Medicine Market
• 8.6 Spanish Electroceutical Medicine Market
• 8.7 Italian Electroceutical Medicine Market
• 8.8 United Kingdom Electroceutical Medicine Market

9. APAC Electroceutical Medicine Market

• 9.1 Overview
• 9.2 APAC Electroceutical Medicine Market by type
• 9.3 APAC Electroceutical Medicine Market by application
• 9.4 Japanese Electroceutical Medicine Market
• 9.5 Indian Electroceutical Medicine Market
• 9.6 Chinese Electroceutical Medicine Market
• 9.7 South Korean Electroceutical Medicine Market
• 9.8 Indonesian Electroceutical Medicine Market

10. ROW Electroceutical Medicine Market

• 10.1 Overview
• 10.2 ROW Electroceutical Medicine Market by type
• 10.3 ROW Electroceutical Medicine Market by application
• 10.4 Middle Eastern Electroceutical Medicine Market
• 10.5 South American Electroceutical Medicine Market
• 10.6 African Electroceutical Medicine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Electroceutical Medicine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Medtronic
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 St Jude Medical
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Boston Scientific Corporation
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Cochlear Limited
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Sonova Holding AG
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Livanova
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Biotronik
  • Company Overview
  • Electroceutical Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us